[1]吴桥伟,李 立,邵秋季,等.Pipeline Flex血流导向装置治疗后循环大型动脉瘤单中心临床经验 [J].介入放射学杂志,2021,30(01):1-4.
 WU Qiaowei,LI Li,SHAO Qiuji,et al.Pipeline Flex embolization device for the treatment of posterior circulation large aneurysms: single-center clinical experience[J].journal interventional radiology,2021,30(01):1-4.
点击复制

Pipeline Flex血流导向装置治疗后循环大型动脉瘤单中心临床经验 
()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
30
期数:
2021年01
页码:
1-4
栏目:
神经介入
出版日期:
2021-01-25

文章信息/Info

Title:
Pipeline Flex embolization device for the treatment of posterior circulation large aneurysms: single-center clinical experience
作者:
吴桥伟 李 立 邵秋季 贺迎坤 李天晓 李 航 白卫星
Author(s):
WU Qiaowei LI Li SHAO Qiuji HE Yingkun LI Tianxiao LI Hang BAI Weixin.
Department of Cerebrovascular Disease, People’s Hospital of Zhengzhou University, Henan Provincial People’s Hospital, Zhengzhou, Henan Province 450003, China
关键词:
【关键词】 血流导向装置后循环动脉瘤颅内动脉瘤大型随访研究
文献标志码:
A
摘要:
【摘要】 目的 探讨Pipeline Flex血流导向装置(PED)治疗后循环大型动脉瘤(PCLA)的安全性和有效性。方法 回顾性纳入2018年6月至2019年9月在郑州大学人民医院接受PED治疗的14例PCLA患者(14枚动脉瘤,最大径≥10 mm)。均为单发未破裂动脉瘤,位于基底动脉主干3例,椎动脉V4段11例。采用改良Rankin量表(mRS)评分评估患者临床预后,O’Kelly-Marotta(OKM)分级评估动脉瘤闭塞情况。 结果 14例患者植入14枚PED,其中4例结合弹簧圈填塞,手术均获成功,支架均成功释放且贴壁良好。未发现神经系统并发症,出院时mRS评分 2分1例,1分2例,0分11例。14例患者均获临床中位随访8(2~18)个月,疗效良好(mRS评分均为0分);11例获DSA中位随访6(3~7)个月,OKM分级D级 7例,C级1例,B级3例,均未见支架内狭窄。 结论 PED治疗PCLA成功率高,安全性好,6个月影像学随访有较高的完全闭塞率。

参考文献/References:

[1] Wiebers DO,Whisnant JP, Huston J 3rd, et al. Unruptured intracranial aneurysms:natural history,clinical outcome,and risks of surgical and endovascular treatment[J]. Lancet, 2003, 362: 103- 110.
[2] Li H, Gao BL, Li CH, et al. Endovascular retreatment of cerebral aneurysms previously treated with endovascular embolization[J]. J Neurol Surg A Cent Eur Neurosurg, 2020, 81:207- 212.
[3] Chalouhi N, Tjoumakaris S, Gonzalez LF, et al. Coiling of large and giant aneurysms:complications and long- term results of 334 cases[J]. AJNR Am J Neuroradiol, 2014, 35: 546- 552.
[4] Zeeshan Q, Ghodke BV, Juric- Sekhar G, et al. Surgery for very large and giant intracranial aneurysms: results and complications[J]. Neurol India, 2018, 66: 1741- 1757.
[5] Luzzi S, Gallieni M, Del Maestro M, et al. Giant and very large intracranial aneurysms:surgical strategies and special issues[J]. Acta Neurochir Suppl, 2018, 129: 25- 31.
[6] 贺迎坤,姜卫剑,李天晓,等. 基底动脉干大动脉瘤及巨大动脉瘤的诊疗研究进展[J]. 中华放射学杂志, 2018, 52:75- 78.
[7] Cagnazzo F, Mantilla D, Rouchaud A, et al. Endovascular treat-ment of very large and giant intracranial aneurysms: comparison between reconstructive and deconstructive techniques: a meta- analysis[J]. AJNR Am J Neuroradiol, 2018, 39: 852- 858.
[8] 李 航,贺迎坤,白卫星,等. Pipeline血流导向装置治疗复杂颅内动脉瘤的安全性及中期疗效[J]. 中华神经外科杂志, 2018, 34:442- 446.
[9] Becske T, Kallmes DF, Saatci I, et al. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial[J]. Radiology, 2013, 267: 858- 868.
[10] 李 立,李天晓,邵秋季,等. 血流导向装置治疗小型未破裂颅内动脉瘤的短期疗效[J]. 中华神经外科杂志, 2019, 35:1099- 1102.
[11] Brouillard AM, Sun X, Siddiqui AH, et al. The use of flow diversion for the treatment of intracranial aneurysms: expansion of indications[J]. Cureus, 2016, 8: e472.
[12] O’kelly CJ. Krings T, Fiorella D, et al. A novel grading scale for the angiographic assessment of intracranial aneurysms treated using flow diverting stents[J]. Interv Neuroradiol, 2010, 16: 133- 137.
[13] Li MH, Chen SW, Li YD, et al. Prevalence of unruptured cerebral aneurysms in Chinese adults aged 35 to 75 years: a cross- sectional study[J]. Ann Intern Med, 2013, 159: 514- 521.
[14] Mizutani T, Aruga T, Kirino T, et al. Recurrent subarachnoid hemorrhage from untreated ruptured vertebrobasilar dissecting aneurysms[J]. Neurosurgery, 1995, 36: 905- 911.
[15] 李钊硕,李天晓,薛绛宇,等. 介入治疗基底动脉夹层动脉瘤效果分析[J]. 介入放射学杂志, 2016, 25:478- 482.
[16] Marosfoi M, Langan ET, Strittmatter L, et al. In situ tissue engineering: endothelial growth patterns as a function of flow diverter design[J]. J Neurointerv Surg, 2017, 9: 994- 998.
[17] 贺迎坤,李天晓,李 航,等. Pipeline血流导向装置治疗国人大型脑动脉瘤围手术期并发症分析[J]. 介入放射学杂志,2018, 27:713- 716.
[18] Kallmes DF, Brinjikji W, Cekirge S, et al. Safety and efficacy of the Pipeline embolization device for treatment of intracranial aneurysms: a pooled analysis of 3 large studies[J]. J Neurosurg, 2017, 127: 775- 780.
[19] Liang F, Zhang Y, Guo F, et al. Use of pipeline embolization device for posterior circulation aneurysms: single- center experi-ences with comparison with anterior circulation aneurysms[J]. World Neurosurg, 2018, 112: e683- e690.
[20] Bhogal P, Perez MA, Ganslandt O, et al. Treatment of posterior circulation non- saccular aneurysms with flow diverters: a single- center experience and review of 56 patients[J]. J Neurointerv Surg, 2017, 9: 471- 481.
[21] Kiyofuji S, Graffeo CS, Perry A, et al. Meta- analysis of treatment outcomes of posterior circulation non- saccular aneurysms by flow diverters[J]. J Neurointerv Surg, 2018, 10: 493- 499.
[22] Liang XD, Wang ZL, Li TX, et al. Safety and efficacy of a new prophylactic tirofiban protocol without oral intraoperative antip-latelet therapy for endovascular treatment of ruptured intracranial aneurysms[J]. J Neurointerv Surg, 2016, 8: 1148- 1153.
[23] Miyachi S, Hiramatsu R, Ohnishi H, et al. Usefulness of the Pipeline embolic device for large and giant carotid cavernous aneurysms[J]. Neurointervention, 2017, 12: 83- 90.

备注/Memo

备注/Memo:
(收稿日期:2020- 01- 16)
(本文编辑:边 佶)
更新日期/Last Update: 2021-01-25